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provide the most compelling evidence
to date to support a role for ESCRT-III
in retroviral budding. They show that
a conserved hydrophobic patch on
the ALIX Bro1 domain is required for
binding to CHMP4/ESCRT-III, and
they use an elegant overexpression
system to demonstrate that the ALIX/
ESCRT-III interaction is essential for
YPXnL-mediated L domain activity.
This experimental approach has also
proved helpful in identifying an unex-
pected functional requirement in the
C-terminal PRR of ALIX. The nature
of this new activity is unclear, but it is
likely that it points to an as yet un-
identified binding partner required for
L domain activity. Identifying this com-
ponent will provide important insights
into how ALIX, and possibly ESCRT-
III, contribute to virus release and the
formation of MVBs.
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The inflammasome is a macromolecular complex responsible for the proteolytic processing and
activation of the secreted cytokine IL-1b. It is assembled and activated in response to upstream
intracellular sensors of microbial components and cell injury. Now, Faustin et al. describe an in vitro
cell-free reconstitution of the inflammasome, opening up a new avenue to better understand this
innate immune pathway of microbe sensing.Caspase-1 is an essential regulator of
cytokine production and inflammation.
Originally isolated as a biochemical
activity capable of proteolytically con-
verting pro-IL-1b into its active and
mature form, caspase-1 also plays an
essential role in processing IL-18
(Cerretti et al., 1992; Thornberry et al.,
1992). Caspase-1 deficiency is associ-
ated with increased susceptibility to
some infections. In isolated cells, pro-
duction of IL-1b can be stimulated bya variety proinflammatory substances,
including pathogen-derived products,
microbial pore-forming toxins, and
monosodium urate crystals (Nadiri
et al., 2006). Until recently, the intra-
cellular signaling mechanisms that
lead to caspase-1 activation were
largely speculative.
A recently described gene family,
the CATERPILLER/NLR (nucleotide-
binding domain, leucine-rich region)
family share a homologous nucleotide-Cell Host & Micrbinding domain and generalized do-
main structure with Apaf-1 (apoptotic
protease-activating factor-1) (Harton
et al., 2002; Inohara and Nunez, 2003).
A number of the protein products of
this gene family have been implicated
in caspase-1 activation. When overex-
pressed, cryopyrin/NALP3, Pypaf 5,
Pypaf-7/Monarch, and IPAF/CARD12
have all been shown to induce IL-1b
secretion and caspase-1 activation.
Because their carboxyl-terminalobe 1, March 2007 ª2007 Elsevier Inc. 7
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resemble the extracellular domains of
the toll-like receptor, this family has
been hypothesized to represent intra-
cellular sensors for pathogen-associ-
ated molecular patterns (PAMPs). Re-
cent studies of cryopyrin show that it
is essential for caspase-1 activation
in response to a broad range of po-
tential PAMPs, suggesting that it might
be an adaptor that integrates signals
from numerous PAMPs rather than
a receptor for PAMPs (Mariathasan
and Monack, 2007).
The mechanism by which these mol-
ecules may activate caspase-1 has
been modeled on our understanding
of the activation of the apoptosis-in-
ducing protease caspase-9 by Apaf-1.
Caspase-9 assembles with Apaf-1,
dATP, and cytochrome c into a
seven-spoked, wheel-shaped, macro-
molecular, caspase-3-activating holo-
enzyme known as the apoptosome
(Zou et al., 1999). Martinon et al. dem-
onstrated that caspase-1, the pyrin
and card domain-containing protein
ASC1, the CATERPILLER/NLR protein
NALP1, and caspase-5 in lysates
from LPS-stimulated macrophage cell
lines assemble into a large-molecu-
lar-weight complex in vitro (Martinon
et al., 2002). Subsequently, cryopyrin
was shown to participate in a similar
complex that included an additional
protein, TUCAN (Agostini et al., 2004).
Although hypothesized to function as
IL-1b-processing holoenzymes that
are activated in response to exposure
to specific PAMPs, regulation of the
assembly and activity of these inflam-
masomes remains to be clarified.
In their recent work, Faustin et al.
(2007) provide a formal demonstration
that NALP1 and procaspase-1 are the
only proteins required to reconstitute
caspase-1 activation in a cell-free
system. In a system containing re-
combinant, purified NALP1 and pro-
caspase-1, the activity of caspase-1,
measured against a peptide substrate,
can be stimulated by the addition of
the microbial component muramyl-
dipeptide (MDP), which is a constituent
of bacterial peptidoglycan and nucleo-
tide triphosphate (NTP) as cofactors.
Although there is no published evi-
dence suggesting that NALP1 requires
MDP to stimulate processed IL-1b re-8 Cell Host & Microbe 1, March 2007 ª2Figure 1. Working Model of the Two-Stage Activation of NALP1 in Inflammasome
Assembly
In this working model, NALP1 is bound to nucleotide diphosphate (NDP, red triangle) in a closed
(black square) conformation in the basal state. Association of NALP1 with MDP (gold star) induces
an open (white squares) conformation, allowing NDP release and binding of nucleotide triphos-
phate (NTP, red and green rectangle). Hydrolysis of NTP to NDP with release of pyrophosphate
(green triangle) by Nalp1 drives a conformational change to the activated (asterisk) state, which
then assembles with procaspase-1 to generate the pro-IL-1b-processing inflammasome. This
model presumes a NDP-bound basal state and a 1:1 caspase-1:NALP1 stoichiometry in the active
holoenzyme, which has not been demonstrated. As noted in the text, other possibilities for the in-
active, basal state of NALP1 include NTP-bound NALP1 with MDP triggering nucleotide hydrolysis
and release or empty NALP1 with MDP triggering opening of a nucleotide-binding site.lease or caspase-1 activation in vivo,
Faustin and colleagues show that the
inactive MDP enantiomer (DD-MDP)
and g-Tri-diaminopimelic acid both
fail to stimulate caspase-1 activity,
suggesting NALP1-mediated cas-
pase-1 activation is specifically stimu-
lated by MDP.
As with the apoptosome, Faustin
and colleagues (Faustin et al., 2007)
show that nucleotides are critical co-
factors in inflammasome assembly.
However, in striking contrast to spe-
cific nucleotide binding by the related
proteins CIITA, IPAF, Apaf-1, and plant
R proteins, NALP1 shows surprisingly
little nucleotide base specificity. De-
spite the protein’s ability to utilize mul-
tiple nucleotide bases to support its
activation, modifications of the ribose
or g phosphate of the nucleotides de-
stroy the nucleotide’s ability to support
the activation of caspase-1. MDP in-
duces a shift in native electrophoretic
mobility of NALP1 and is required to
observe direct binding of a fluorescent007 Elsevier Inc.ATP analog, Fluoroscein-ATP12(FL-
ATP), to NALP1. Deleting the LRR of
NALP1 produces a protein capable
of binding FL-ATP in the absence of
MDP, suggesting the LRR acts intra-
molecularly to maintain the basal, inac-
tive form of NALP1 and is required for
the protein to be responsive to MDP.
These data suggest a two-step model
of activation in which MDP allows bind-
ing of NTP, which then induces oligo-
merization and resultant activation of
caspase-1 (working model is shown
in Figure 1). However, a caveat is that
direct binding of MDP to recombinant
NALP1 was not shown, hence the ex-
act mechanism by which MDP exerts
its effects is not known. Nonhydrolyz-
able NTP analogs did not support
activation of Caspase-1 activity or olig-
omerization of NALP1, suggesting that
nucleotide hydrolysis may drive the
conformational change that activates
NALP1 and allows oligomerization.
Though clearly a significant advance
for the field of inflammasome study,
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set of important questions revolving
around the ‘‘inflammasome.’’ Although
certain murine polymorphisms in
Nalp1b appear to dictate the response
to anthrax lethal toxin, the involvement
of NALP1 in recognizing MDP in vitro
suggests that this protein is important
in the detection of a broad array of bac-
terial pathogens (Boyden and Dietrich,
2006). NOD2, another NLR family
member, appears to be essential for
the activation of NFkB in response to
MDP and has long been considered
a candidate as an intracellular MDP
sensor. The role of NALP1 in the phys-
iologic response to MDP in intact cells
or animals (i.e., the in vivo correlation
of the in vitro reconstitution) and the
identity of the MDP sensor in a physio-
logical setting remain major unre-
solved issues. Further, although cas-
pase-1 was previously demonstrated
to be active within a NALP1-containing
complex that includes other proteins,
Faustin et al. (2007) clearly demon-
strate that cleaved, active caspase-1
is generated in the presence of
NALP1 with the mere addition of MDP
and NTP. The cleaved caspase-1 mayViral Evasion of A
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Restriction of both bacterial and
In this issue of Cell Host & Micro
autophagy by a viral gene produ
Autophagy constitutes, in addition to
proteasomal degradation, a second
major catabolic process for the turn-
over of cytoplasmic constituents of eu-
karyotic cells (Kim and Klionsky, 2000).
The biological process of autophagy is
comprised of at least three pathways,
macroautophagy, microautophagy,represent active enzyme released
from the inflammasome by cleavage
of the regulatory CARD domain. Addi-
tion of purified caspase-5 and ASC
might clarify their roles. Finally, the
nucleotide-binding cycle, and its role
in NALP1-inflammasome assembly,
remain mysterious. NALP1 may be
empty or bound to either NTP or NDP
in the basal state (Figure 1). Depending
on the initial state of NALP1, MDP may
induce a nucleotide-binding-compe-
tent conformation, release of diphos-
phate nucleotide, or hydrolysis of
triphosphate nucleotide.
Though many questions remain re-
garding both the assembly of the
NALP1 inflammasome and the gener-
alizability of NALP1 activation to other
NLR proteins, Faustin and colleagues
have clearly laid out the viability of
using reconstitution of caspase-1
activation as a method to study host-
pathogen interactions.
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